Graves’ disease is an autoimmune disorder that stimulates the thyroid gland to release excessive thyroid hormone, leading to hyperthyroidism. It is termed as Basedow’s disease in continental Europe and Graves’ disease in the U.S. In this disease, body’s immune system produces antibodies that help the thyroid gland to grow which in turn synthesizes abnormal levels of thyroid hormones causing hyperthyroidism.
This report contains market size and forecasts of Graves Disease in Global, including the following market information:
Global Graves Disease Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Graves Disease market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-Thyroid Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Graves Disease include Abbott Laboratories, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, RLC LABS, AbbVie, Inc, Mylan N.V and Allergan, plc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Graves Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Graves Disease Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Graves Disease Market Segment Percentages, by Type, 2021 (%)
Anti-Thyroid Drugs
Lodine &Lodides
Radioactive Lodine
Lonic Inhibitors
Global Graves Disease Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Graves Disease Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Global Graves Disease Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Graves Disease Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Graves Disease revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Graves Disease revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
GlaxoSmithKline plc
Merck & Co
Pfizer, Inc
RLC LABS
AbbVie, Inc
Mylan N.V
Allergan, plc